Show Notes
Both underground and above-ground therapists and practitioners present their psychedelic services in service to "healing." Why, then, is it so hard to get them to acknowledge the harms taking place in their communities? Why do institutions seem more concerned with preserving their reputations than addressing the numerous harmful dynamics that have persisted for years? If the psychedelic movement intends to heal trauma, it must begin at home.
This episode is Psymposia's reaction to Cover Story: Power Trip, Episode 9: The Complainers Group
Cover Story is an investigative podcast from New York Magazine. The first season, Power Trip, uncovers the secrets and exposes the darkest corners of the psychedelic renaissance through a twisted, deeply personal tale at the intersection of mind, body, and control. Power Trip is a co-production of New York Magazine and Psymposia.
Support:
☼Patreon: http://patreon.com/psymposia ☼Donate: https://www.psymposia.com/donate/ For full episodes, transcripts, supporting documents, and more, visit: https://psymposia.com/powertrip
Follow:
☼Twitter: https://twitter.com/psymposia ☼Instagram: https://www.instagram.com/psymposia/ ☼Facebook: https://www.facebook.com/psymposia ☼Twitch: https://www.twitch.tv/psymposia ☼Website: https://www.psymposia.com ☼Podcast: https://www.psymposia.com/plusthree ☼Newsletter: https://www.psymposia.com/subscribe/
More from The Psymposia Podcast
Normie, Mike, and Neşe discuss the upcoming MAHA Summit and its psychedelic pharmaceutical sponsors.
The crew discusses the FDA's September 14 psychedelic hearing, including Neşe's experience being in attendance, the financial conflicts of interest at the event, and the pseudoscientific beliefs of practitioners who gave testimony. Footnotes: Submit written comment to the FDA by October 5, 2026 https://www.federalregister.gov/documents/2026/07/14/2026-14155/considerations-for-potential-future-therapeutic-use-of-psychedelic-drugs-public-hearing-request-for
Psymposia dives into the recent Rolling Stone article — "Reggie Watts Is a Prominent Ketamine Advocate. Was It His Ex's 'Undoing'?" — and explores how the dynamics at play in that article are pervasive within the psychedelic advocacy scene. Footnotes: Reggie Watts Is a Prominent Ketamine Advocate. Was It His Ex's 'Undoing'? (Rolling Stone): https://www.rollingstone.com/tv-movies/tv-movie-features/reggie-watts-ketamine-drug-advocate-1235607828/ Ending The Silence Around Psychedelic Therapy Abuse (Mad In America): https://www.madinamerica.com/2021/09/ending-silence-psychedelic-therapy-abuse/ Cover Story: Power Trip (Psymposia): https://www.psymposia.com/powertrip-2/ The Psychedelic Syndicate (Psymposia): https://www.psymposia.com/psychedelic-syndicate-executive-summary-silicon-valley-maps-lykos-mdma-fda-billionaires/index.html
Psymposia interviews YouTube documentarian @Alex-Novell about his experience with Andrew Callaghan and Channel 5, drug legalization, and creating documentary films. Thumbnail terminator image provided by Alex Novell.
Psymposia discusses takeaways from their "Psychedelic Conversion Therapy" series and reflects on the ten year anniversary of their "Coming Out of the Psychedelic Closet" series.